Literature DB >> 22591852

Functional analysis of synonymous substitutions predicted to affect splicing of the CFTR gene.

Alexandra Scott1, Hanna M Petrykowska, Timothy Hefferon, Valer Gotea, Laura Elnitski.   

Abstract

BACKGROUND: Cystic fibrosis is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Over 1800 CFTR mutations have been reported, and about 12% of mutations are believed to impair pre-mRNA splicing. Given that several synthetic, non-splice-junction synonymous substitutions have been reported to alter splicing in CFTR, we predicted that naturally occurring synonymous substitutions may be erroneously classified as functionally neutral.
METHODS: Computational tools were used to predict the effect of synonymous substitutions on CFTR pre-mRNA splicing. The functional consequences of selected substitutions were evaluated using a minigene splicing assay.
RESULTS: Two synonymous mutations were shown to have a dramatic effect on CFTR pre-mRNA splicing, and consequently could alter protein integrity and phenotypic outcome.
CONCLUSIONS: Traditional methods of mutation analysis overlook splicing defects that occur at internal positions in coding exons, especially synonymous substitutions. We show that bioinformatics tools and minigene splicing assays are a potent combination to prioritize and identify mutations that cause aberrant CFTR pre-mRNA splicing. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22591852      PMCID: PMC3440543          DOI: 10.1016/j.jcf.2012.04.009

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  27 in total

1.  Artemis: sequence visualization and annotation.

Authors:  K Rutherford; J Parkhill; J Crook; T Horsnell; P Rice; M A Rajandream; B Barrell
Journal:  Bioinformatics       Date:  2000-10       Impact factor: 6.937

2.  A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes.

Authors:  H X Liu; L Cartegni; M Q Zhang; A R Krainer
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

3.  BLAT--the BLAST-like alignment tool.

Authors:  W James Kent
Journal:  Genome Res       Date:  2002-04       Impact factor: 9.043

Review 4.  Listening to silence and understanding nonsense: exonic mutations that affect splicing.

Authors:  Luca Cartegni; Shern L Chew; Adrian R Krainer
Journal:  Nat Rev Genet       Date:  2002-04       Impact factor: 53.242

5.  Intronic sequences flanking alternatively spliced exons are conserved between human and mouse.

Authors:  Rotem Sorek; Gil Ast
Journal:  Genome Res       Date:  2003-07       Impact factor: 9.043

6.  Complete and rapid scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by denaturing high-performance liquid chromatography (D-HPLC): major implications for genetic counselling.

Authors:  C Le Maréchal; M P Audrézet; I Quéré; O Raguénès; S Langonné; C Férec
Journal:  Hum Genet       Date:  2001-04       Impact factor: 4.132

7.  Splicing defects in the CFTR gene: minigene analysis of two mutations, 1811+1G>C and 1898+3A>G.

Authors:  Gwendal Dujardin; Diane Commandeur; Catherine Le Jossic-Corcos; Claude Ferec; Laurent Corcos
Journal:  J Cyst Fibros       Date:  2011-02-12       Impact factor: 5.482

8.  Characterization of disease-associated mutations affecting an exonic splicing enhancer and two cryptic splice sites in exon 13 of the cystic fibrosis transmembrane conductance regulator gene.

Authors:  Isabel Aznarez; Elayne M Chan; Julian Zielenski; Benjamin J Blencowe; Lap-Chee Tsui
Journal:  Hum Mol Genet       Date:  2003-08-15       Impact factor: 6.150

9.  Missense, nonsense, and neutral mutations define juxtaposed regulatory elements of splicing in cystic fibrosis transmembrane regulator exon 9.

Authors:  Franco Pagani; Emanuele Buratti; Cristiana Stuani; Francisco E Baralle
Journal:  J Biol Chem       Date:  2003-05-05       Impact factor: 5.157

10.  New type of disease causing mutations: the example of the composite exonic regulatory elements of splicing in CFTR exon 12.

Authors:  Franco Pagani; Cristiana Stuani; Maria Tzetis; Emmanuel Kanavakis; Alexandra Efthymiadou; Stavros Doudounakis; Teresa Casals; Francisco E Baralle
Journal:  Hum Mol Genet       Date:  2003-05-15       Impact factor: 6.150

View more
  10 in total

1.  Experimental assessment of splicing variants using expression minigenes and comparison with in silico predictions.

Authors:  Neeraj Sharma; Patrick R Sosnay; Anabela S Ramalho; Christopher Douville; Arianna Franca; Laura B Gottschalk; Jeenah Park; Melissa Lee; Briana Vecchio-Pagan; Karen S Raraigh; Margarida D Amaral; Rachel Karchin; Garry R Cutting
Journal:  Hum Mutat       Date:  2014-09-10       Impact factor: 4.878

Review 2.  The functional relevance of somatic synonymous mutations in melanoma and other cancers.

Authors:  Valer Gotea; Jared J Gartner; Nouar Qutob; Laura Elnitski; Yardena Samuels
Journal:  Pigment Cell Melanoma Res       Date:  2015-11       Impact factor: 4.693

3.  CAGI experiments: Modeling sequence variant impact on gene splicing using predictions from computational tools.

Authors:  Valer Gotea; Gennady Margolin; Laura Elnitski
Journal:  Hum Mutat       Date:  2019-06-27       Impact factor: 4.700

4.  Synonymous variants associated with Alzheimer disease in multiplex families.

Authors:  Min Tang; Maria Eugenia Alaniz; Daniel Felsky; Badri Vardarajan; Dolly Reyes-Dumeyer; Rafael Lantigua; Martin Medrano; David A Bennett; Philip L de Jager; Richard Mayeux; Ismael Santa-Maria; Christiane Reitz
Journal:  Neurol Genet       Date:  2020-06-08

5.  A rigorous approach for selection of optimal variant sets for carrier screening with demonstration of clinical utility.

Authors:  Cynthia Perreault-Micale; Jocelyn Davie; Benjamin Breton; Stephanie Hallam; Valerie Greger
Journal:  Mol Genet Genomic Med       Date:  2015-04-23       Impact factor: 2.183

6.  Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene.

Authors:  Patrick R Sosnay; Karen R Siklosi; Fredrick Van Goor; Kyle Kaniecki; Haihui Yu; Neeraj Sharma; Anabela S Ramalho; Margarida D Amaral; Ruslan Dorfman; Julian Zielenski; David L Masica; Rachel Karchin; Linda Millen; Philip J Thomas; George P Patrinos; Mary Corey; Michelle H Lewis; Johanna M Rommens; Carlo Castellani; Christopher M Penland; Garry R Cutting
Journal:  Nat Genet       Date:  2013-08-25       Impact factor: 38.330

7.  Analysis of long-range interactions in primary human cells identifies cooperative CFTR regulatory elements.

Authors:  Stéphanie Moisan; Soizik Berlivet; Chandran Ka; Gérald Le Gac; Josée Dostie; Claude Férec
Journal:  Nucleic Acids Res       Date:  2015-11-28       Impact factor: 16.971

8.  regSNPs-splicing: a tool for prioritizing synonymous single-nucleotide substitution.

Authors:  Xinjun Zhang; Meng Li; Hai Lin; Xi Rao; Weixing Feng; Yuedong Yang; Matthew Mort; David N Cooper; Yue Wang; Yadong Wang; Clark Wells; Yaoqi Zhou; Yunlong Liu
Journal:  Hum Genet       Date:  2017-04-08       Impact factor: 5.881

9.  Evaluation of both exonic and intronic variants for effects on RNA splicing allows for accurate assessment of the effectiveness of precision therapies.

Authors:  Anya T Joynt; Taylor A Evans; Matthew J Pellicore; Emily F Davis-Marcisak; Melis A Aksit; Alice C Eastman; Shivani U Patel; Kathleen C Paul; Derek L Osorio; Alyssa D Bowling; Calvin U Cotton; Karen S Raraigh; Natalie E West; Christian A Merlo; Garry R Cutting; Neeraj Sharma
Journal:  PLoS Genet       Date:  2020-10-21       Impact factor: 5.917

Review 10.  Principles and Practical Considerations for the Analysis of Disease-Associated Alternative Splicing Events Using the Gateway Cloning-Based Minigene Vectors pDESTsplice and pSpliceExpress.

Authors:  Elena Putscher; Michael Hecker; Brit Fitzner; Peter Lorenz; Uwe Klaus Zettl
Journal:  Int J Mol Sci       Date:  2021-05-13       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.